CCL22 and neoplasm: reported that elevated L1 cell adhesion molecule (L1CAM) expression in ESCC cells could facilitate CCL22 expression by activating the PI3K/Akt/NF-κB signaling pathway, thereby promoting Tregs recruitment to the tumor site (84).